We use engineering approaches to develop 1) new therapies that promote regeneration of brain and spinal cord tissues and 2) improved preclinical models of brain tumors.

A common theme across many pathologies of central nervous system, including cancer and spinal cord injury, is significant alterations to the extracellular matrix, such as changes in biochemical composition and structural mechanics of the tissue. A lack of understanding of how the extracellular matrix is fundamentally altered by injury or disease, and thus how these changes may be reversed to restore normal function, has been a major limitation to the development of new treatments. My lab develops tools for investigating the unique extracellular environment in the central nervous system and its relationship to cell function. We use biomimetic, hydrogel-based microenvironments with modular features that can be tuned to quantify independent effects of various extracellular parameters over cell phenotype and behavior and, in turn, provide a means for precise external control over cell and tissue function. Furthermore, we are developing methods for high-throughput assays of live cells cultured within these same biomaterial platforms. Acquisition of dynamic, high-throughput data from cells cultured in physiologically relevant conditions will provide new insights into pathologies of the central nervous system and, ultimately, more effective therapies for these conditions.

News

Mar 12, 2021

New publication on biomaterial-mediated gene delivery for spinal cord injury

Congrats to Arshia on the final first author publication from his PhD – just out in APL Bioengineering (https://aip.scitation.org/journal/apb). A. Ehsanipour, M. Sathialingam, L.M. Rad, J. de Rutte, R.D. Bierman, J. Liang, W. Xiao, D. Di Carlo, S.K. Seidlits. Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord. (2021) APL Bioengineering, published online March 2021. Featured…
Mar 12, 2021

New Lab Members in 2020!

Welcome to our new lab members who joined during the 2020 pandemic! First, we welcome post-doc researcher Soniya Bastola, who has extensive experience in glioblastoma and earned her PhD at the University of Alabama. Next, we welcome 1st year PhD student Jing Wang, who recently earned his MS in biomedical engineering from Columbia. Most recently, we welcome MS student Bushra…
Jul 31, 2020

Postdoctoral Position in Cancer Tissue Engineering

Postdoctoral Position in Cancer Tissue Engineering, University of California Los Angeles Job Description: A post-doctoral position in the laboratory of Stephanie Seidlits in the Department of Bioengineering at UCLA is available to start immediately. We are seeking candidates for a multidisciplinary project developing tissue-engineered models of glioblastoma tumors as platforms for personalized medicine that can predict patient outcomes within a…
Mar 06, 2020

New Lab Members!

A huge welcome to the newest lab members: post-doctoral researchers Ze Zhong (Bill) Wang and Elham Hatami. Dr. Wang recently received his Ph.D. from Washington University in St. Louis, while Dr. Hatami recently received her Ph.D. from the University of Tennessee Health Science Center. Excited to have you both on board!
Feb 27, 2020

New R01 Grant from NIH NCI Funded!

Excited to announce our recently funded R01 grant from the National Institutes of Health (NIH) National Cancer Institute (NCI)! The project, titled Tissue-engineered models of microvessel-mediated glioblastoma invasion, will apply a tissue-engineered model of the interface between glioblastoma and its associated blood vessels for systematic characterization of the mechanisms by which blood vessels promote glioblastoma cells to migrate away from…

Copyright 2017 Seidlits Research Group © All Rights Reserved | UCLA